Ernexa Therapeutics Inc. Financing Cash Flow
Ernexa Therapeutics Inc. (ERNA) reported Financing Cash Flow of $9.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $6.00K, a 99.88% decline year-over-year.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $9.56M, a 324.09% increase year-over-year.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $26.00K, a 99.33% decline year-over-year.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2025 was $7.21M, a 15.16% increase from fiscal 2024.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2024 was $6.26M, a 62.19% decline from fiscal 2023.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2023 was $16.56M, a 15.44% decline from fiscal 2022.
- Ernexa Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2022 was $19.58M, a 68.21% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.56M 10-Q · filed 2026-08-06 | $9.56M derived: sum of 3 quarters · filed 2026-08-06 | $9.59M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $9.56M 10-Q · filed 2026-05-11 | $9.56M derived: sum of 2 quarters · filed 2026-05-11 | $9.59M derived: sum of 3 quarters · filed 2026-05-11 | $14.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $26.00K derived: sum of 2 quarters · filed 2026-03-13 | $4.96M derived: sum of 3 quarters · filed 2026-08-06 | $7.21M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.96M derived: sum of 2 quarters · filed 2026-08-06 | $7.21M 10-Q · filed 2025-11-07 | $8.22M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $4.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.18M 10-Q · filed 2026-08-06 | $8.19M derived: sum of 3 quarters · filed 2026-08-06 | $12.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.25M 10-Q · filed 2026-05-11 | $3.26M derived: sum of 2 quarters · filed 2026-05-11 | $7.15M derived: sum of 3 quarters · filed 2026-05-11 | $7.13M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $4.90M derived: sum of 2 quarters · filed 2026-03-13 | $4.88M derived: sum of 3 quarters · filed 2026-03-13 | $6.26M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.87M derived: sum of 2 quarters · filed 2025-11-07 | $5.25M 10-Q · filed 2025-11-07 | $12.95M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.36M 10-Q · filed 2025-08-13 | $9.07M derived: sum of 3 quarters · filed 2025-08-13 | $17.61M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-07 | $9.09M derived: sum of 2 quarters · filed 2025-05-07 | $17.63M derived: sum of 3 quarters · filed 2025-05-07 | $17.94M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $16.24M derived: sum of 2 quarters · filed 2025-03-12 | $16.56M derived: sum of 3 quarters · filed 2025-03-12 | $16.56M 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | $8.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.85M derived: sum of 2 quarters · filed 2024-11-12 | $8.85M 10-Q · filed 2024-11-12 | $16.45M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $312.00K 10-Q · filed 2024-08-13 | $7.91M derived: sum of 3 quarters · filed 2024-08-13 | $7.91M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $7.59M derived: sum of 2 quarters · filed 2024-05-14 | $7.60M derived: sum of 3 quarters · filed 2024-05-14 | $7.59M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $7.60M derived: sum of 2 quarters · filed 2024-03-14 | $7.59M derived: sum of 3 quarters · filed 2024-03-14 | $19.58M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$7.00K derived: sum of 2 quarters · filed 2023-11-13 | $11.99M 10-Q · filed 2023-11-13 | $11.57M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $11.98M 10-Q · filed 2023-08-11 | $11.56M derived: sum of 3 quarters · filed 2023-08-11 | $15.06M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $11.99M 10-Q · filed 2023-05-11 | $11.57M derived: sum of 2 quarters · filed 2023-05-11 | $15.07M derived: sum of 3 quarters · filed 2023-05-11 | $63.63M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $3.08M derived: sum of 2 quarters · filed 2023-03-20 | $51.64M derived: sum of 3 quarters · filed 2023-03-20 | $61.59M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $52.06M derived: sum of 2 quarters · filed 2022-11-14 | $62.00M 10-Q · filed 2022-11-14 | $62.00M 10-Q · filed 2021-11-12 | $62.23M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $48.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $58.50M 10-Q · filed 2022-08-11 | $58.50M 10-Q · filed 2021-08-13 | $58.73M derived: sum of 3 quarters · filed 2022-08-11 | $59.00M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $9.94M 10-Q · filed 2022-07-01 | $9.94M 10-Q · filed 2021-05-17 | $10.17M derived: sum of 2 quarters · filed 2022-07-01 | $10.44M derived: sum of 3 quarters · filed 2022-07-01 | $14.30M derived: sum of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | $225.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $500.35K derived: sum of 2 quarters · filed 2022-07-01 | $4.36M derived: sum of 3 quarters · filed 2022-07-01 | $4.67M 10-K/A · filed 2022-07-01 | $291.00K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $4.13M derived: sum of 2 quarters · filed 2021-11-12 | $4.44M 10-Q · filed 2021-11-12 | $1.76M 10-Q · filed 2020-11-13 | $4.17M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $4.17M 10-Q · filed 2021-08-13 | $1.62M 10-Q · filed 2020-08-07 | $3.90M derived: sum of 3 quarters · filed 2021-08-13 | $3.54M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $312.50K 10-Q · filed 2021-05-17 | $388.00K 10-Q · filed 2020-05-20 | $40.50K derived: sum of 2 quarters · filed 2021-05-17 | -$317.50K derived: sum of 3 quarters · filed 2021-05-17 | -$512.50K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$630.00K derived: sum of 2 quarters · filed 2021-03-11 | -$825.00K derived: sum of 3 quarters · filed 2021-03-11 | -$1.10M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$553.00K derived: sum of 2 quarters · filed 2020-11-13 | -$826.00K 10-Q · filed 2020-11-13 | -$1.31M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$468.00K 10-Q · filed 2020-08-07 | -$952.00K derived: sum of 3 quarters · filed 2020-08-07 | -$1.69M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | -$273.00K 10-Q · filed 2020-05-20 | -$757.00K derived: sum of 2 quarters · filed 2020-05-20 | -$1.50M derived: sum of 3 quarters · filed 2020-05-20 | -$350.00K derived: sum of 4 quarters · filed 2020-05-20 | ||||
| 2018-12-31 | -$484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$1.22M derived: sum of 2 quarters · filed 2020-03-19 | -$77.00K derived: sum of 3 quarters · filed 2020-03-19 | -$303.00K 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | -$740.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $407.00K derived: sum of 2 quarters · filed 2019-11-01 | $181.00K 10-Q · filed 2019-11-01 | -$57.00K derived: sum of 4 quarters · filed 2019-11-01 | ||||
| 2018-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $921.00K 10-Q · filed 2019-08-12 | $683.00K derived: sum of 3 quarters · filed 2019-08-12 | $438.00K derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | -$226.00K 10-Q · filed 2019-05-14 | -$464.00K derived: sum of 2 quarters · filed 2019-05-14 | -$709.00K derived: sum of 3 quarters · filed 2019-05-14 | -$2.83M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$483.00K derived: sum of 2 quarters · filed 2019-03-22 | -$2.60M derived: sum of 3 quarters · filed 2019-03-22 | -$1.47M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$2.37M derived: sum of 2 quarters · filed 2018-11-09 | -$1.23M 10-Q · filed 2018-11-09 | $1.56M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$985.00K 10-Q · filed 2018-08-06 | $1.81M derived: sum of 3 quarters · filed 2018-08-06 | $1.52M derived: sum of 4 quarters · filed 2018-08-06 | ||||
| 2017-03-31 | $1.14M 10-Q · filed 2018-05-11 | $3.93M derived: sum of 2 quarters · filed 2018-05-11 | $3.64M derived: sum of 3 quarters · filed 2018-05-11 | $3.34M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.51M derived: sum of 2 quarters · filed 2018-03-09 | $2.20M derived: sum of 3 quarters · filed 2018-03-09 | $3.26M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | -$284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$589.00K derived: sum of 2 quarters · filed 2017-11-08 | $464.00K 10-Q · filed 2017-11-08 | $1.32M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | -$305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $748.00K 10-Q · filed 2017-08-04 | $1.60M derived: sum of 3 quarters · filed 2017-08-04 | $2.52M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $1.05M 10-Q · filed 2017-05-04 | $1.91M derived: sum of 2 quarters · filed 2017-05-04 | $2.83M derived: sum of 3 quarters · filed 2017-05-04 | $3.67M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | $857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.78M derived: sum of 2 quarters · filed 2017-03-09 | $2.61M derived: sum of 3 quarters · filed 2017-03-09 | $1.98M 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | $919.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.75M derived: sum of 2 quarters · filed 2016-11-09 | $1.12M 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | $836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $204.00K 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | -$632.00K 10-Q · filed 2016-05-09 | |||||||
| 2013-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $206.00K derived: sum of 2 quarters · filed 2013-11-14 | $145.00K 10-Q · filed 2013-11-14 | $64.00K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2013-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $29.00K 10-Q · filed 2013-08-14 | -$52.00K derived: sum of 3 quarters · filed 2013-08-14 | -$138.00K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2013-03-31 | -$61.00K 10-Q · filed 2013-05-13 | -$142.00K derived: sum of 2 quarters · filed 2013-05-13 | -$228.00K derived: sum of 3 quarters · filed 2013-11-14 | -$314.00K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$167.00K derived: sum of 2 quarters · filed 2013-11-14 | -$253.00K derived: sum of 3 quarters · filed 2013-11-14 | $1.95M 10-K · filed 2013-03-29 | ||||
| 2012-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$172.00K derived: sum of 2 quarters · filed 2013-11-14 | $2.03M 10-Q · filed 2013-11-14 | $1.91M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $2.12M 10-Q · filed 2013-08-14 | $2.00M derived: sum of 3 quarters · filed 2013-08-14 | $2.03M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $2.21M 10-Q · filed 2013-05-13 | $2.09M derived: sum of 2 quarters · filed 2013-05-13 | $2.11M derived: sum of 3 quarters · filed 2013-05-13 | $2.00M derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$93.00K derived: sum of 2 quarters · filed 2013-03-29 | -$204.00K derived: sum of 3 quarters · filed 2013-03-29 | -$300.00K 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$85.00K derived: sum of 2 quarters · filed 2012-11-09 | -$181.00K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | -$111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$207.00K 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$96.00K 10-Q · filed 2012-05-11 | |||||||
| 2010-12-31 | -$364.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |